TET2 and myelodysplastic syndrome: However, the effect of TET2 nucleotide variants and that of reduced TET2 expression on the expected reduction in 5-hmC levels is not conclusive, and reports on the effect of a reduced 5-hmC level, if any, on the prognosis of MDS are conflicting [21, 22].